Babak

NIOME (SN55): Synthetic Genomic Intelligence on Bittensor Pharmaceutical companies and precision medicine researchers face a problem that almost nobody talks about openly. @NiomeAI is building the solution. To train AI models capable of predicting drug responses, modeling rare diseases, or advancing pharmacogenomics, you need genomic data at a scale most people don't appreciate. We're talking hundreds of thousands to millions of individual genomes, and the infrastructure to produce that safely simply hasn't existed until now. The scale required to make these tools actually work is enormous, and the catch is that real human DNA is, for all practical purposes, untouchable. Privacy legislation like GDPR and HIPAA creates significant regulatory exposure. Obtaining genuine informed consent at scale is a logistical nightmare. And the consequences of a breach are severe, not just legally, but for the individuals whose most intimate biological data gets exposed. The 23andMe hack wasn't a one-off incident. It was a preview of what happens when sensitive genomic data is centralized and inadequately protected. The result is a genuine bottleneck in medical science. The data exists in theory. The need is urgent and well-documented. But the pipeline between real-world genomic information and the researchers who need it is almost entirely blocked. What NIOME is building NIOME, running as Subnet 55 on Bittensor, takes a fundamentally different approach. Instead of trying to unlock access to real patient data, the project generates synthetic genomes. These are artificial DNA sequences produced by decentralized AI that are statistically indistinguishable from real human genomic data, but contain zero actual patient information. This isn't a rough approximation either. The synthetic genomes preserve the properties that make genomic data scientifically useful: allele frequencies, linkage disequilibrium patterns, population structure, and other biological markers that researchers rely on for meaningful analysis. The output looks and behaves like real genomic data because it's engineered to replicate the underlying statistical architecture of the human genome. Just without any individual ever having contributed to it. No privacy risk. No GDPR or HIPAA exposure. No consent requirements. No breach liability. And no ceiling on scale. How the subnet works The mechanics are standard Bittensor incentive design applied to a genuinely novel problem. Miners on SN55 generate synthetic genomes and earn $TAO based on the quality of their output. Validators assess each submission for biological realism and statistical fidelity, making sure the genomic data produced actually meets the standards required for serious research use. The competitive structure drives continuous improvement across the network over time. The end result is a decentralized, continuously improving data layer for the life sciences. Something that gets more capable the more miners compete to produce better output. What it unlocks The use cases are wide and the implications are significant. Synthetic cohorts at scale open up drug response prediction, rare disease modeling, gene editing simulation, and pharmacogenomics research in ways that were previously blocked by data access constraints. Research institutions, biotech companies, and pharmaceutical firms can build and validate AI models without ever touching a real patient's DNA. This is what the $44 billion precision medicine market looks like when it finally gets the data infrastructure it needs to move faster. Who's behind it NIOME is built by the team behind genomes.io, a genomic data platform backed by Pantera Capital, Modular Capital, and ConsenSys. That's not a random assortment of names. These are investors with serious track records in crypto infrastructure and Web3, and their backing of genomes.io signals conviction in both the team and the broader thesis around decentralized biological data. The NIOME subnet is accelerated by @YumaGroup and is live on Bittensor mainnet as SN55. The combination of genuine domain knowledge, institutional-grade backing, decentralized AI infrastructure, and an unsolved problem in medical research makes this one of the more credible projects in the current Bittensor ecosystem. Follow @NiomeAI for updates. #Bittensor #TAO #NIOME #DeSci #SyntheticBiology #PrecisionMedicine

Vladimir Putin's plan to make humans live for 150 years is in process under supervision of Russian scientists 🔎 “ Denis Sekirinsky, a Russian science and education minister, claimed his country's researchers are on course…” msn.com/en-ae/news/oth…